{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:02:55Z","timestamp":1770418975169,"version":"3.49.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Fingolimod (FTY720) is a drug derived from the fungicidal compound myriocin. As it was unclear whether FTY720 has antifungal effects as well, we aimed to characterize its effect on <jats:italic>Candida albicans in vitro<\/jats:italic> and in a mouse candidiasis model. First, antifungal susceptibility testing was performed <jats:italic>in vitro<\/jats:italic>. Then, a randomized, six-arm, parallel, open-label trial was conducted on 48 mice receiving oral FTY720 (0.3 mg\/kg\/day), intraperitoneal <jats:italic>C<\/jats:italic>. <jats:italic>albicans<\/jats:italic> inoculation, or placebo with different combinations and chorological patterns. The outcome measures of the trial included serum concentrations of interleukin-10 and interferon-gamma, absolute lymphocyte counts, and fungal burden values in the mice\u2019s livers, kidneys, and vaginas. Broth microdilution assay revealed FTY720\u2019s minimum inhibitory concentration (MIC<jats:sub>99<\/jats:sub>) to be 0.25 mg\/mL for <jats:italic>C<\/jats:italic>. <jats:italic>albicans<\/jats:italic>. The infected mice treated with FTY720 showed lower fungal burden values than the ones not treated with FTY720 (<jats:italic>p<\/jats:italic>&lt;0.05). As expected, the mice treated with FTY720 showed a less-inflammatory immune profile compared to the ones not treated with FTY720. We hypothesize that FTY720 synergizes the host\u2019s innate immune functions by inducing the production of reactive oxygen species. Further studies are warranted to unveil the mechanistic explanations of our observations and clarify further aspects of repurposing FTY720 for clinical antifungal usage.<\/jats:p>","DOI":"10.1371\/journal.pone.0278488","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:38:40Z","timestamp":1670438320000},"page":"e0278488","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model"],"prefix":"10.1371","volume":"17","author":[{"given":"Niloofar","family":"Najarzadegan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboobeh","family":"Madani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2796-6791","authenticated-orcid":true,"given":"Nahad","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"4","key":"pone.0278488.ref001","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/14712598.2020.1732919","article-title":"Modulation of sphingosine-1-phosphate in ulcerative colitis.","volume":"20","author":"M Argollo","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"pone.0278488.ref002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn\u2019s disease and ulcerative colitis?","volume":"77","author":"KF Baker","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"pone.0278488.ref003","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3892\/or.2013.2765","article-title":"FTY720 for cancer therapy","volume":"30","author":"L Zhang","year":"2013","journal-title":"Oncol Rep"},{"issue":"4","key":"pone.0278488.ref004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40263-021-00798-w","article-title":"Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis.","volume":"35","author":"R Roy","year":"2021","journal-title":"CNS Drugs"},{"issue":"5","key":"pone.0278488.ref005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"L Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"pone.0278488.ref006","first-page":"Cd009371","article-title":"Fingolimod for relapsing-remitting multiple sclerosis.","volume":"4","author":"L La Mantia","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0278488.ref007","first-page":"1132","article-title":"Different doses of fingolimod in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.","volume":"12","author":"X Wu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"pone.0278488.ref008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2042098613481023","article-title":"Fingolimod and cardiac risk: latest findings and clinical implications.","volume":"4","author":"WS Vargas","year":"2013","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"pone.0278488.ref009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11596550-000000000-00000","article-title":"Clinical pharmacokinetics of fingolimod.","volume":"51","author":"OJ David","year":"2012","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"pone.0278488.ref010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/CPJ.0000000000000027","article-title":"Fingolimod and macular edema: Pathophysiology, diagnosis, and management.","volume":"4","author":"S Cugati","year":"2014","journal-title":"Neurol Clin Pract"},{"key":"pone.0278488.ref011","article-title":"Weight Loss and Loss of Appetite as a Side Effect of Fingolimod (Preprint).","author":"M Etemadifar","year":"2022","journal-title":"Res Sq."},{"issue":"6","key":"pone.0278488.ref012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4155\/fmc.12.25","article-title":"Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis","volume":"4","author":"K Chiba","year":"2012","journal-title":"Future Med Chem"},{"issue":"1","key":"pone.0278488.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-015-0588-0","article-title":"Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm","volume":"15","author":"F Perdoni","year":"2015","journal-title":"BMC Microbiol"},{"issue":"3","key":"pone.0278488.ref014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1248\/bpb.b20-00246","article-title":"Study on the Inhibitory Activity and Possible Mechanism of Myriocin on Clinically Relevant Drug-Resistant Candida albicans and Its Biofilms","volume":"44","author":"X Yang","year":"2021","journal-title":"Biol Pharm Bull"},{"key":"pone.0278488.ref015","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4397159","article-title":"More than just an immunosuppressant: the emerging role of FTY720 as a novel inducer of ROS and apoptosis.","volume":"2018","author":"T Takasaki","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"pone.0278488.ref016","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458516670732","article-title":"Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: here come the opportunistic infections?","volume":"23","author":"AF Carpenter","year":"2017","journal-title":"Mult Scler"},{"issue":"3","key":"pone.0278488.ref017","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001156","article-title":"Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series.","volume":"9","author":"M Del Poeta","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"pone.0278488.ref018","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species.","volume":"7","author":"SG Whaley","year":"2017","journal-title":"Front Microbiol"},{"issue":"5","key":"pone.0278488.ref019","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s15010-020-01475-8","article-title":"Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.","volume":"48","author":"AT Coste","year":"2020","journal-title":"Infection"},{"issue":"1","key":"pone.0278488.ref020","article-title":"On Commensalism of Candida.","volume":"6","author":"JA Romo","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"pone.0278488.ref021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/0471142735.im1906s105","article-title":"Animal models for candidiasis.","volume":"105","author":"HR Conti","year":"2014","journal-title":"Curr Protoc Immunol"},{"key":"pone.0278488.ref022","unstructured":"EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.1 Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Files\/EUCAST_E_Def_7_3_1_Yeast_testing__definitive.pdf (2017). Accessed November 2022."},{"key":"pone.0278488.ref023","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","edition":"8"},{"key":"pone.0278488.ref024","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.intimp.2016.07.027","article-title":"Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy","volume":"39","author":"CS Abdullah","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"pone.0278488.ref025","doi-asserted-by":"crossref","first-page":"e0170825","DOI":"10.1371\/journal.pone.0170825","article-title":"Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.","volume":"12","author":"T Bonfiglio","year":"2017","journal-title":"PLoS One."},{"issue":"2","key":"pone.0278488.ref026","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11596-012-0035-5","article-title":"Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft.","volume":"32","author":"Q Cheng","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"11","key":"pone.0278488.ref027","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1038\/tp.2015.179","article-title":"Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.","volume":"5","author":"P Efstathopoulos","year":"2015","journal-title":"Transl Psychiatry"},{"issue":"12","key":"pone.0278488.ref028","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.CIR.100.12.1322","article-title":"FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation","volume":"100","author":"MW Hwang","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"pone.0278488.ref029","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.4049\/jimmunol.164.11.5761","article-title":"FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory","volume":"164","author":"DD Pinschewer","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"pone.0278488.ref030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/FJC.0000000000000031","article-title":"The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction","volume":"63","author":"G Wang","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"pone.0278488.ref031","volume-title":"AVMA guidelines for the euthanasia of animals.","author":"W Underwood","year":"2020"},{"key":"pone.0278488.ref032","unstructured":"JoVE Science Education Database. Basic Methods in Cellular and Molecular Biology. Using a Hemacytometer to Count Cells.: https:\/\/www.jove.com\/v\/5048\/using-a-hemacytometer-to-count-cells (2022). Accessed November 2022."},{"issue":"2","key":"pone.0278488.ref033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1214\/aoms\/1177730256","article-title":"Table for Estimating the Goodness of Fit of Empirical Distributions","volume":"19","author":"N. Smirnov","year":"1948","journal-title":"Ann Math Statist"},{"key":"pone.0278488.ref034","first-page":"83","article-title":"Sulla determinazione empirica di una lgge di distribuzione","volume":"4","author":"A. Kolmogorov","year":"1933","journal-title":"Giornale dell\u2019Istituto Italiano degli Attuari."},{"issue":"3","key":"pone.0278488.ref035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","article-title":"Adaptive linear step-up procedures that control the false discovery rate","volume":"93","author":"Y Benjamini","year":"2006","journal-title":"Biometrika"},{"issue":"346","key":"pone.0278488.ref036","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/01621459.1974.10482955","article-title":"Robust tests for the equality of variances","volume":"69","author":"MB Brown","year":"1974","journal-title":"J Am Stat Assoc"},{"issue":"1\u20132","key":"pone.0278488.ref037","first-page":"28","article-title":"The Generalization of \u2018Student\u2019s\u2019 Problem When Several Different Population Variances are Involved.","volume":"34","author":"BL Welch","year":"1947","journal-title":"Biometrika"},{"key":"pone.0278488.ref038","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a718","article-title":"Enhancing the quality and transparency of health research","volume":"337","author":"T. Groves","year":"2008","journal-title":"BMJ"},{"key":"pone.0278488.ref039","first-page":"346","article-title":"Fingolimod potentiates the antifungal activity of amphotericin B","volume":"11","author":"L-Q Wei","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"pone.0278488.ref040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/gtc.12134","article-title":"FTY 720 stimulated ROS generation and the S ty1\/A tf1 signaling pathway in the fission yeast S chizosaccharomyces pombe","volume":"19","author":"K Hagihara","year":"2014","journal-title":"Genes Cells"},{"issue":"9","key":"pone.0278488.ref041","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1124\/dmd.105.009001","article-title":"Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2 [2-(-4-octylphenyl) ethyl] propane-1, 3-diol hydrochloride) in rats after oral and intravenous doses.","volume":"34","author":"GM Meno-Tetang","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"pone.0278488.ref042","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1567-1364.2010.00613.x","article-title":"Expression of Candida albicans glutathione transferases is induced inside phagocytes and upon diverse environmental stresses","volume":"10","author":"A Garcer\u00e1","year":"2010","journal-title":"FEMS Yeast Res"},{"issue":"10","key":"pone.0278488.ref043","doi-asserted-by":"crossref","first-page":"e1003634","DOI":"10.1371\/journal.ppat.1003634","article-title":"NADPH oxidase-driven phagocyte recruitment controls Candida albicans filamentous growth and prevents mortality.","volume":"9","author":"KM Brothers","year":"2013","journal-title":"PLoS Pathog"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:39:15Z","timestamp":1670438355000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278488"}},"subtitle":[],"editor":[{"given":"Aijaz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278488","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}